PCVX - Balance Sheet - Vaxcyte, Inc.

Current Liabilities	140 M
Accounts Payable	48.5 M
Short-Term Debt	0
Other Current Liabilities	91.7 M
Non-Current Liabilities	65.3 M
Long-Term Debt	0
Other Non-Current Liabilities	65.3 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	387.9	397.5	834.7	69.0	386.2	59.0	66.1	36.1
Short Term Investments	1 359.3	682.8	96.7	177.0	0	0	0	0
Receivables	0	0	0	0	0	0	0	0
Inventory	0	0	(1.0)	(1.2)	(0.3)	(0.2)	0	0
Other Current Assets	40.8	15.7	5.3	9.2	2.5	2.7	0.6	0.2
Total Current Assets	1 788.0	1 096.0	942.6	256.3	389.0	61.7	66.7	36.3
PP&E	270.1	110.6	31.6	35.9	3.3	3.4	3.4	3.0
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	1 387.5	162.7	26.5	27.1	0	0	0	0
Other Long Term Assets	65.7	38.7	5.4	5.0	0.6	0.6	0.7	0.3
Other Assets	0	0	0	0	0	0	0	0
Total Assets	3 511.3	1 407.9	1 006.2	324.3	392.8	65.7	70.8	39.6
LIABILITIES
Accounts Payable	48.5	14.6	9.8	6.8	29.8	3.4	2.8	1.8
Short Term Debt	0	7.1	11.8	10.6	0	0.2	0.3	0.3
Other Current Liabilities	91.7	123.6	18.9	11.4	17.1	7.5	3.6	2.2
Total Current Liabilities	140.2	145.3	40.5	28.7	46.9	11.1	6.7	4.3
Long Term Debt	0	22.1	12.0	11.5	0	0	0.2	4.2
Deferred Tax Income	0	0	0	0	0	0	0	0
Other Liabilities	65.3	0	9 K	96 K	0.1	161.0	121.7	0.2
Total Liabilities	205.5	167.4	52.6	40.3	47.0	172.1	128.5	8.7
EQUITY
Common Stock	0.1	98 K	82 K	56 K	54 K	7 K	6 K	6 K
Retained Earnings	(1 388.3)	(924.4)	(522.1)	(298.6)	(198.6)	(109.3)	(59.1)	(29.6)
Other Accumulative Comprehensive Income/Loss	(3.9)	0.2	(0.4)	(0.2)	(392.8)	(160.3)	(1.8)	0
Total Equity	3 305.8	1 240.5	953.6	284.0	345.8	(106.4)	(57.7)	30.9
Total Liabilities and Equity	3 511.3	1 407.9	1 006.2	324.3	392.8	65.7	70.8	39.6
SHARES OUTSTANDING
Common Shares Outstanding	122.0	97.2	64.9	51.9	29.5	3.8	3.6	3.6

Free